About Remepy
Remepy is a company based in United States founded in 2022 by Michal Tsur.. Remepy has raised $15 million across 2 funding rounds from investors including TechAviv, NFX and Vine Ventures. Remepy offers products and services including Hybrid Drugs and Therapeutic App. Remepy operates in a competitive market with competitors including Omda, MICA, Ataraxis, Significo and Kiro, among others.
- Headquarter United States
- Founders Michal Tsur
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Remepy, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15 M (USD)
in 2 rounds
-
Latest Funding Round
$10 M (USD), Seed
May 01, 2024
-
Investors
TechAviv
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Remepy
Remepy offers a comprehensive portfolio of products and services, including Hybrid Drugs and Therapeutic App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drugs integrated with software to enhance effectiveness for various diseases.
App providing tailored interventions to support drug treatments.
Unlock access to complete
Unlock access to complete
Funding Insights of Remepy
Remepy has successfully raised a total of $15M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $10 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $10.0M
-
First Round
First Round
(01 Jun 2023)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Seed - Remepy | Valuation | NFX | |
| Jun, 2023 | Amount | Seed - Remepy | Valuation | TechAviv |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Remepy
Remepy has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include TechAviv, NFX and Vine Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm offering funding and tools for startups in technology and investment sectors.
|
Founded Year | Domain | Location | |
|
Venture capital investments are directed toward early-stage technology companies.
|
Founded Year | Domain | Location | |
|
PsyMed Ventures is focused on funding mental health innovations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Remepy
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Remepy
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Remepy Comparisons
Competitors of Remepy
Remepy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omda, MICA, Ataraxis, Significo and Kiro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regulatory and security compliant software solutions are provided by Omda.
|
|
| domain | founded_year | HQ Location |
AI-based decision support systems are provided for radiologists.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based diagnostic platform
|
|
| domain | founded_year | HQ Location |
Software development services are provided by Significo in Austin.
|
|
| domain | founded_year | HQ Location |
AI development services for healthcare sectors are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Remepy
Frequently Asked Questions about Remepy
When was Remepy founded?
Remepy was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is Remepy located?
Remepy is headquartered in United States.
Is Remepy a funded company?
Remepy is a funded company, having raised a total of $15M across 2 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Jun 01, 2023.
What does Remepy do?
Remepy was established in 2022 in the United States as a provider of healthcare software application services. Operations are centered on delivering software solutions tailored to healthcare needs, including application development and support. The company is led by co-founder Michal Tsur. Services encompass various digital tools for healthcare providers, with a focus on efficiency in medical workflows. Geographic presence is maintained within the U.S. market.
Who are the top competitors of Remepy?
Remepy's top competitors include Digital Autopsy, Ataraxis and MICA.
What products or services does Remepy offer?
Remepy offers Hybrid Drugs and Therapeutic App.
Who are Remepy's investors?
Remepy has 10 investors. Key investors include TechAviv, NFX, Vine Ventures, PsyMed Ventures, and Firstime Ventures.